INSIGHTS ON PHARMACEUTICAL PACKAGING

PHARMACEUTICAL PACKAGING SOLUTIONS

  • We provide a flexible and dynamic approach to GMP manufacturing. From first in human (FIH) through to phase 3 clinical supplies manufacturing at our MHRA Approved and Home Office Approved (I-IV) GMP facility, Trent Gateway.

  • Integrated device assembly, labeling, and packaging solutions streamline pharma delivery, ensuring compliance, scalability, and patient-centric design from clinical trials to commercial production.

  • Used MGS horizontal continuous motion cartoner, model Stealth, with powered carton magazine, feed belt, glue closure with Nordon gluer, PLc controls with HMI screen, kick reject station, 230 volt, serial# 12726, built 2008.

  • The Food and Drug Administration (FDA), United States Pharmacopeia (USP) and EMA Annex 1 issue strict guidelines for testing the integrity of IV bags and containers closed by fusion. IV bag manufacturers are one among many sterile product manufacturers that must meet these test requirements for container closure integrity.

  • The United States Pharmacopeia USP 1207 guidance has been revised, encouraging the preference to deterministic, quantitative, and reliable non-destructive technologies to comply with quality standards.